Clinical Trial

Pharmaco Mechanical Thrombolysis Associated With Anticoagulation Compared With Anticoagulation in the Acute Phase of Very Symptomatic Proximal Venous Thrombosis of the Lower Limbs.

Study acronym: PMT-DVT
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
* Iliofemoral DVTs (IF DVTs) are vascular disorders associated with high morbidity and mortality, which can be complicated by long-term post-thrombotic syndrome (PTS). * Pharmaco mechanical thrombolysis (PMT) is an innovative endovascular technique involving in situ fibrinolysis of the thrombus in the acute phase of thrombosis, followed by mechanical extraction by fragmenting the thrombus. * The American ATTRACT study showed that management by catheter-directed thrombolysis and/or PMT in the acute phase is safe and effective at 2 years in a subgroup of DVTif compared with anticoagulation (18% moderate or severe SPT with thrombolysis vs. 28% without thrombolysis). * PMT-DVT will be the first study to assess the medium (30 months) and long-term (60 months) efficacy of PMT in the French context, using data from the French National Health Data System.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-24.
Status change: Not Yet Recruiting → Recruiting 2026-05-21
Trial Details
NCT Number NCT06472518
Lead Sponsor Nantes University Hospital
Conditions Iliofemoral Venous Thrombosis
Enrollment 228 participants
Start Date 2026-05-20
Primary Completion 2027-03-01 (estimated)
Study Completion 2029-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-26